Alcami Corp - Strategic SWOT Analysis Review

November 2021 | 33 pages | ID: A5D6463EAC9EN
GlobalData

Abstracts

Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Alcami Corp (Alcami), formerly AAIPharma Services Corp/Cambridge Major Laboratories, Inc (AAI/CML) is a contract development and manufacturing company (CDMO) that offers a comprehensive range of pharmaceutical development and manufacturing services to small and mid-size pharmaceutical and biotechnology companies across the world. The company’s major services include active pharmaceutical ingredients (API) development and manufacturing, solid-state chemistry development, packaging, formulation development, clinical and commercial finished dosage form manufacturing, packaging and stability services, and analytical development and testing services. The company operates through its facilities and offices in the US, the Netherlands, and Japan. Alcami is headquartered in Wilmington, North Carolina, the US.

Alcami Corp Key Recent Developments

Oct 19,2021: PharmaTher engages Alcami for clinical and commercial manufacturing of novel ketamine products
Oct 12,2021: Alcami Announces Parenteral Operations Leadership Appointments
Sep 29,2021: Alcami expands parenteral operations with additional investment
Aug 10,2021: Alcami Appoints Timothy Compton as Chief Business Officer
Mar 18,2021: Alcami appoints Patrick D. Walsh as Chairman and Chief Executive Officer

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Alcami Corp - Key Facts
Alcami Corp - Key Employees
Alcami Corp - Key Employee Biographies
Alcami Corp - Major Products and Services
Alcami Corp - History
Alcami Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Alcami Corp - Business Description
Alcami Corp - SWOT Analysis
SWOT Analysis - Overview
Alcami Corp - Strengths
Alcami Corp - Weaknesses
Alcami Corp - Opportunities
Alcami Corp - Threats
Alcami Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Alcami Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 19, 2021: PharmaTher engages Alcami for clinical and commercial manufacturing of novel ketamine products
Oct 12, 2021: Alcami Announces Parenteral Operations Leadership Appointments
Sep 29, 2021: Alcami expands parenteral operations with additional investment
Aug 10, 2021: Alcami Appoints Timothy Compton as Chief Business Officer
Mar 18, 2021: Alcami appoints Patrick D. Walsh as Chairman and Chief Executive Officer
Jan 07, 2021: Alcami expands oral solid capabilities with investment in Wilmington
Sep 29, 2020: Alcami hosting virtual open house of new sterile fill-finish development & manufacturing facility
Jul 28, 2020: Alcami RTP Expansion Nears Completion
Jun 04, 2020: Alcami appoints Walter J. Kaczmarek III as Chief Executive Officer
May 21, 2020: Alcami continues to strengthen senior leadership team with appointment of quality and regulatory leaders

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Alcami Corp, Key Facts
Alcami Corp, Key Employees
Alcami Corp, Key Employee Biographies
Alcami Corp, Major Products and Services
Alcami Corp, History
Alcami Corp, Other Locations
Alcami Corp, Key Competitors
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Alcami Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Alcami Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Alcami Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Alcami Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021